What Experts Say About Us - AME Publishing Company

CDT review articles, particularly those comprising special series issues, are world class! Residents and fellows across specialties have taken notice. It is no surprise that the impact factor of the journal is soaring.

Michael A. Winkler
Editorial Board Member of Cardiovascular Diagnosis and Therapy
Department of Radiology
University of Kentucky Chandler Medical Center, Lexington, KY, USA

Written on Aug 15, 2023

It has been a pleasure to follow the development of TLCR almost from the beginning and meet the enthusiastic young team implementing this project. In a very short time, TLCR has become one of the leading international lung cancer journals and a must-read for everyone involved in this topic.

Prof. Jacek Jassem
Editorial Board Member of Translational Lung Cancer Research
Department of Oncology and Radiotherapy
Medical University of Gdańsk, Poland

Written on Aug 9, 2023

We live in a transformative and innovative time, and medicine is also experiencing such change. The best way to approach this time is through a multidisciplinary approach. Translation Lung Cancer Research (TLCR) is one of the best platforms for this, covering genomics, imaging, biomarkers, and state-of-the-art treatment. TLCR has been contributing to innovation in lung cancer research and practices, and I am confident that it will continue to do so.

Chang Min Park
Editorial Board Member of Translational Lung Cancer Research
Department of Radiology
Seoul National University College of Medicine
Seoul National University Hospital, Seoul, Republic of Korea

Written on Jul 25, 2023

I have witnessed the growth and relevance of the CDT journal over the years, and happy to be part of the Editorial Board. The topics of the papers are well chosen, of high quality and highly relevant from a clinical and research perspective. I see a great future for the CDT journal.

Johan (Hans) HC Reiber, PhD, FESC, FACC
Editorial Board Member of Cardiovascular Diagnosis and Therapy
Professor of Medical Imaging
Division of Image Processing
Department of Radiology
Leiden University Medical Center, Leiden, Netherlands

Written on August 3, 2023

As an Editorial Board Member of Cardiovascular Diagnosis and Therapy (CDT), I am impressed by the great quality and clinical relevance of the papers published in the journal, that transpired into a higher impact factor and CiteScore. Based on these elements and the outstanding work of the editorial team, I am convinced that CDT will become one of the preeminent journals in the field of cardiovascular medicine.

Adriano R. Tonelli, MD
Editorial Board Member of Cardiovascular Diagnosis and Therapy
Department of Pulmonary, Allergy, and Critical Care Medicine, Respiratory Institute, Cleveland, OH, USA

Written on August 1, 2023

It is great to see the impact factor and CiteScore at the top of the VATS homepage! As readers become even more selective about what they read, and have time to read, the usefulness of VATS’ subjects and the quality of the writing will continue to position us well.

Mark R. Katlic, MD, MMM, FACS
Editorial Board Member of Video-Assisted Thoracic Surgery
Department of Surgery, Sinai Hospital of Baltimore, Baltimore, MD, USA

Written on July 26, 2023